50 related articles for article (PubMed ID: 12184436)
1. Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients.
Brocq O; Tran G; Breuil V; Grisot C; Flory P; Euller-Ziegler L
Joint Bone Spine; 2002 Jun; 69(4):388-91. PubMed ID: 12184436
[TBL] [Abstract][Full Text] [Related]
2. Intra-articular Injections of Cross-linked Hyaluronic Acid in Japanese Patients with Symptomatic Osteoarthritis of the Hip.
Koyano G; Jinno T; Koga D; Hoshino C; Okawa A
Prog Rehabil Med; 2021; 6():20210038. PubMed ID: 34632157
[TBL] [Abstract][Full Text] [Related]
3. Molecular Weight of Hyaluronic Acid Has Major Influence on Its Efficacy and Safety for Viscosupplementation in Hip Osteoarthritis: A Systematic Review and Meta-Analysis.
Wu YZ; Huang HT; Ho CJ; Shih CL; Chen CH; Cheng TL; Wang YC; Lin SY
Cartilage; 2021 Dec; 13(1_suppl):169S-184S. PubMed ID: 34109828
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of viscosupplementation with hyaluronic acid for hip osteoarthritis: results from a cross-sectional study with a minimum follow-up of 4 years.
Schiavi P; Calderazzi F; Pedrini MF; Tacci F; Vaienti E; Pogliacomi F
Acta Biomed; 2020 Dec; 91(14-S):e2020032. PubMed ID: 33559627
[TBL] [Abstract][Full Text] [Related]
5. Viscosupplementation for hip osteoarthritis: Does systematic review of patient-reported outcome measures support use?
Acuña AJ; Samuel LT; Jeong SH; Emara AK; Kamath AF
J Orthop; 2020; 21():137-149. PubMed ID: 32255995
[TBL] [Abstract][Full Text] [Related]
6. Intra-Articular Viscosupplementation for Patients with Hip Osteoarthritis: A Meta-Analysis and Systematic Review.
Liao YY; Lin T; Zhu HX; Shi MM; Yan SG
Med Sci Monit; 2019 Aug; 25():6436-6445. PubMed ID: 31454342
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of intra-articular hyaluronic acid injections in hip osteoarthritis: a meta-analysis of randomized controlled trials.
Wu B; Li YM; Liu YC
Oncotarget; 2017 Oct; 8(49):86865-86876. PubMed ID: 29156841
[TBL] [Abstract][Full Text] [Related]
8. Are We Using Slow-Acting Symptomatic Chondroprotective Drugs Conscious Enough?
Gumustas SA; Oznam K; Mutlu CA; Kaya YE; Yilmaz I; Isyar M; Guzelant AY; Guler O; Akkaya S; Mahirogullari M
Open Orthop J; 2017; 11():533-540. PubMed ID: 28694893
[TBL] [Abstract][Full Text] [Related]
9. Viscosupplementation with intra-articular hyaluronic acid for hip disorders. A systematic review and meta-analysis.
Piccirilli E; Oliva F; Murè MA; Mahmoud A; Foti C; Tarantino U; Maffulli N
Muscles Ligaments Tendons J; 2016; 6(3):293-299. PubMed ID: 28066733
[TBL] [Abstract][Full Text] [Related]
10. Differences Regarding Branded HA in Italy, Part 2: Data from Clinical Studies on Knee, Hip, Shoulder, Ankle, Temporomandibular Joint, Vertebral Facets, and Carpometacarpal Joint.
Migliore A; Bizzi E; De Lucia O; Delle Sedie A; Tropea S; Bentivegna M; Mahmoud A; Foti C
Clin Med Insights Arthritis Musculoskelet Disord; 2016; 9():117-31. PubMed ID: 27279754
[TBL] [Abstract][Full Text] [Related]
11. Symposium: evidence for the use of intra-articular cortisone or hyaluronic acid injection in the hip.
Chandrasekaran S; Lodhia P; Suarez-Ahedo C; Vemula SP; Martin TJ; Domb BG
J Hip Preserv Surg; 2016 Apr; 3(1):5-15. PubMed ID: 27026814
[TBL] [Abstract][Full Text] [Related]
12. Bilateral Hip Joint Hylan G-F 20 Granulomatous Synovitis due to Viscosupplementation Injections.
Weinrauch P; Trigger R; Tsikleas G
Case Rep Orthop; 2014; 2014():494073. PubMed ID: 25210640
[TBL] [Abstract][Full Text] [Related]
13. Total hip replacement rate in a cohort of patients affected by symptomatic hip osteoarthritis following intra-articular sodium hyaluronate (MW 1,500-2,000 kDa) ORTOBRIX study.
Migliore A; Bella A; Bisignani M; Calderaro M; De Amicis D; Logroscino G; Mariottini F; Moreschini O; Massafra U; Bizzi E; Laganà B; Piscitelli P; Tormenta S
Clin Rheumatol; 2012 Aug; 31(8):1187-96. PubMed ID: 22678146
[TBL] [Abstract][Full Text] [Related]
14. Hylan g-f 20: review of its safety and efficacy in the management of joint pain in osteoarthritis.
Migliore A; Giovannangeli F; Granata M; Laganà B
Clin Med Insights Arthritis Musculoskelet Disord; 2010 Sep; 3():55-68. PubMed ID: 21151854
[TBL] [Abstract][Full Text] [Related]
15. Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip.
Migliore A; Massafra U; Bizzi E; Vacca F; Martin-Martin S; Granata M; Alimonti A; Tormenta S
Arthritis Res Ther; 2009; 11(6):R183. PubMed ID: 20003205
[TBL] [Abstract][Full Text] [Related]
16. Intra-articular use of hyaluronic acid in the treatment of osteoarthritis.
Migliore A; Granata M
Clin Interv Aging; 2008; 3(2):365-9. PubMed ID: 18686758
[TBL] [Abstract][Full Text] [Related]
17. The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up.
Migliore A; Tormenta S; Martin Martin LS; Iannessi F; Massafra U; Carloni E; Monno D; Alimonti A; Granata M
Clin Rheumatol; 2006 May; 25(3):389-93. PubMed ID: 16249827
[TBL] [Abstract][Full Text] [Related]
18. Potential applications of hyaluronans in orthopaedics: degenerative joint disease, surgical recovery, trauma and sports injuries.
Axe MJ; Shields CL
Sports Med; 2005; 35(10):853-64. PubMed ID: 16180945
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis.
Tikiz C; Unlü Z; Sener A; Efe M; Tüzün C
Clin Rheumatol; 2005 Jun; 24(3):244-50. PubMed ID: 15647968
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
